Bringhen S, Cani L, Giuliani N, Mangiacavalli S, Benevolo G, Antonioli E, Zambello R, Ria R, Vincelli ID, Ronconi S, More S, Falcone AP, Allegra A, D’Agostino M, Evangelista A, Capra A, Sciorsci E, Curci P, Tosi P, Liberati AM, Cafro AM, Belotti A, Patriarca F, Mannina D, Mancuso K, Cattel F, Ciccone G, Bruno B, Boccadoro M, Larocca A. Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial. Haematologica; https://doi.org/10.3324/haematol.2025.287510 [Early view].